File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Alternatives to remifentanil for the analgesic component of total intravenous anaesthesia: a narrative review

TitleAlternatives to remifentanil for the analgesic component of total intravenous anaesthesia: a narrative review
Authors
Issue Date23-Dec-2022
PublisherWiley
Citation
Anaesthesia: Peri-operative medicine, critical care and pain, 2023, v. 78, n. 5, p. 620-625 How to Cite?
Abstract

Propfol-remifentanil-based total intravenous anaesthesia has dominated recent clinical practice due to its favourable pharmacokinetic profile. Interruption in remifentanil supply has presented an opportunity to diversify or even avoid the use of opioids and consider adjuncts to propofol-based total intravenous anaesthesia. Propofol, while a potent hypnotic, is not an effective analgesic. The administration of opioids, along with other adjuncts such as α-2 adrenoceptor agonists, magnesium, lidocaine, ketamine and nitrous oxide provide surgical anaesthesia and avoids large doses of propofol being required. We provide an overview of both target-control and manual infusion regimes for the alternative opioids: alfentanil, sufentanil and fentanyl. The optimal combination of hypnotic-opioid dose, titration sequence and anticipated additional postoperative analgesia required depend on the chosen combination. In addition, we include a brief discussion on the role of non-opioid adjuncts in total intravenous anaesthesia, suggested doses and expected reduction in propofol dose.


Persistent Identifierhttp://hdl.handle.net/10722/328336
ISSN
2023 Impact Factor: 7.5
2023 SCImago Journal Rankings: 2.400
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorHughes, LM-
dc.contributor.authorIrwin, MG-
dc.contributor.authorNestor, CC-
dc.date.accessioned2023-06-28T04:42:34Z-
dc.date.available2023-06-28T04:42:34Z-
dc.date.issued2022-12-23-
dc.identifier.citationAnaesthesia: Peri-operative medicine, critical care and pain, 2023, v. 78, n. 5, p. 620-625-
dc.identifier.issn0003-2409-
dc.identifier.urihttp://hdl.handle.net/10722/328336-
dc.description.abstract<p>Propfol-remifentanil-based total intravenous anaesthesia has dominated recent clinical practice due to its favourable pharmacokinetic profile. Interruption in remifentanil supply has presented an opportunity to diversify or even avoid the use of opioids and consider adjuncts to propofol-based total intravenous anaesthesia. Propofol, while a potent hypnotic, is not an effective analgesic. The administration of opioids, along with other adjuncts such as α-2 adrenoceptor agonists, magnesium, lidocaine, ketamine and nitrous oxide provide surgical anaesthesia and avoids large doses of propofol being required. We provide an overview of both target-control and manual infusion regimes for the alternative opioids: alfentanil, sufentanil and fentanyl. The optimal combination of hypnotic-opioid dose, titration sequence and anticipated additional postoperative analgesia required depend on the chosen combination. In addition, we include a brief discussion on the role of non-opioid adjuncts in total intravenous anaesthesia, suggested doses and expected reduction in propofol dose.<br></p>-
dc.languageeng-
dc.publisherWiley-
dc.relation.ispartofAnaesthesia: Peri-operative medicine, critical care and pain-
dc.titleAlternatives to remifentanil for the analgesic component of total intravenous anaesthesia: a narrative review-
dc.typeArticle-
dc.identifier.doi10.1111/anae.15952-
dc.identifier.hkuros344708-
dc.identifier.volume78-
dc.identifier.issue5-
dc.identifier.spage620-
dc.identifier.epage625-
dc.identifier.eissn1365-2044-
dc.identifier.isiWOS:000901327700001-
dc.identifier.issnl0003-2409-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats